Weekend Update - W2626

▶ Explore this week’s Tape — live, sortable, drill-down →

The Week Memory Stopped Being a Commodity

For forty years, memory was the worst business in technology. Brutally cyclical, structurally commoditized, a graveyard of balance sheets that overbuilt into every upcycle and got buried in the glut that followed. You did not own memory. You rented it, for one cycle, and you got out before the supply caught up. This week Micron told you that business is over — and the people still pricing it as a cycle are fighting the last war.

Start with the number that actually matters, and it is not the print. Yes, Micron guided next quarter to fifty billion dollars against a Street modeling forty-three, and yes, the market cap crossed a trillion.¹ Spikes like that are exactly what the cyclical bears are built to fade. The thing that should stop you is buried below the headline: sixteen legally binding take-or-pay contracts, locking in roughly a fifth of Micron’s DRAM capacity through the end of the decade.² Take-or-pay is the language of pipelines and LNG terminals, not chips. It is what a supplier signs when the buyer is more afraid of not having the product than of overpaying for it. That sentence has never been true about memory before.

This is a capital-cycle story, and the cleanest analog is crude. The oil majors spent decades destroying their own returns by spending every dollar of cash flow drilling into the next price spike. Then, somewhere after 2015, the survivors consolidated and discovered discipline — capex restraint, returns over volume, supply that no longer rushed to kill every upcycle. The multiples did not re-rate because demand exploded. They re-rated because the industry stopped overbuilding. Memory now has three players who matter, AI demand that arrives on multi-year contracts instead of a consumer whim, and customers signing away their option to walk. That is not a cycle turning. That is a commodity becoming a toll road.

And you can read the toll on everyone downstream. Apple raised prices on fourteen products this week and took its worst single day in over a year, with Tim Cook calling the memory spike a hundred-year flood unlike anything in his forty years.³ A company that prints a hundred-thirty billion in trailing free cash flow does not pass costs to the customer over a blip — it eats them. It passes them when the input is structural, and the same week it is quietly lobbying Washington to buy from a blacklisted Chinese supplier just to get the parts.⁴ Oracle is funding its AI cloud with a twenty-four-billion-dollar free-cash-flow deficit and forty billion more in planned debt, the whole build premised on memory it has to secure years out.⁵ Broadcom and OpenAI unveiled a chip designed to cut inference cost in half — which is what you do when the underlying components got expensive enough to engineer around. Every one of those moves is a payment, in a different currency, to the same toll booth.

The cashflow read is in Marcus’s column below — short version: the Cash Flow Memo had Micron going into the print at a hundred-plus times trailing free cash flow, and it was the wrong frame, because the contracts changed what the denominator will look like.

What changes the read is the supply side, and the calendar is short. The test is whether Samsung and SK Hynix hold the same discipline or break ranks and flood capacity into these prices — the move that has ended every prior memory upcycle. Watch the fiscal-2027 capex commitments from all three, and watch whether more take-or-pay contracts get signed or this stays a sixteen-deal anomaly. The thesis breaks the moment one of the three decides that share matters more than price. It always has before.

Wall Street’s consensus on memory: enjoy the spike, the cycle always rolls over, it always has. Sixteen take-or-pay contracts running to 2030 say the cartel finally learned what the oil majors learned — that the most valuable thing you can do with a commodity is refuse to make too much of it.

The Tape — W2626

Universe of 94 cashflow-memo names, snap dates 2026-06-19 → 2026-06-27. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

Micron isn’t in this table, and that’s the point — the print is too fresh and the fiscal-year filing hasn’t landed, so the memo number is already stale. Going into the quarter the memo had it at 102x trailing FCF, which was the wrong frame even then. The reframe is the contract book: 16 take-or-pay deals locking roughly a fifth of DRAM capacity through 2030. Take-or-pay converts a commodity denominator into something closer to contracted revenue, and the screens won’t reprice that until the filings show it. The test is the next fiscal-year filing — and whether Samsung and SK Hynix sign the same paper or break ranks on price.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-06-27.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

Memory Hits Escape Velocity

The week the memory shortage stopped looking like a cycle, and everything downstream paid the bill.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 90-plus companies in the Cash Flow Memo. About 13 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2627.

Chapter markers

* Time | Segment

* 0:15 | Cold open — memory’s escape velocity

* 0:45 | Theme — memory’s downstream: Apple and Oracle

* 4:45 | Deep dive — Micron and Broadcom

* 9:00 | Rapid-fire — Nike, pharma, Meta, Tesla

* 12:15 | Close — Consensus Watch + forward week

Full transcript

Cold open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still in pilot, so tell us what’s working and what isn’t.

Ava: Here’s the one thing to take from this week. Memory hit escape velocity. And everything downstream — Apple’s price tags, Oracle’s balance sheet, the chips hyperscalers are now designing just to get out from under the cost — is a consequence of that one fact. On Wednesday’s show, episode 2626, Hunt, Jason, and Mike flagged the memory squeeze forcing Apple to raise prices.[^ep-e2626] Then Micron reported. And the squeeze stopped looking like a cycle and started looking like a supercycle.

Theme — memory’s downstream

Ava: Start where it hits you at the checkout. Apple just told you the memory shortage has reached the price tag. The company raised prices on 14 products this week — MacBooks up $200, the iPad up to $449, Vision Pro now $3,699.[^aapl-price-hikes-20260625] The stock had its worst day in over a year, down about 6%, roughly $265 billion of market value gone in a session.[^aapl-stock-decline-20260625] And Tim Cook didn’t hedge it. He told the Wall Street Journal memory and storage prices have quadrupled in three quarters, and called it, quote, a hundred-year flood, unlike anything he’s seen in over 40 years.[^aapl-cook-quote-20260625]

Ava: And then the quiet part. The same week Apple raised your prices, it was lobbying the Trump administration for permission to buy memory from ChangXin — a Chinese maker that sits on the Pentagon’s blacklist.[^aapl-cxmt-lobby-20260627] That’s how short memory is. And the talent is chasing the same scarcity — Apple’s head of Vision Pro and smart-glasses engineering left this week for OpenAI’s hardware unit, after seven years on the project.[^aapl-meade-openai-20260626] Marcus — Apple can afford to eat this. Why is it passing it on?

Marcus: Because the flood is real and Apple is telling you it can’t source its way around it. This is a company that prints cash — the memo had Apple at 35 times trailing free cash flow at a roughly 3% yield going in, on about $130 billion of trailing free cash flow.[^memo-aapl-evfcf-20260627][^memo-aapl-fcf-20260627] A company with that cash machine raises prices on the customer only when the input cost is structural, not a blip. The price hikes aren’t the story. The lobbying to buy from a blacklisted supplier is the story. That’s a hardware company admitting the supply chain it actually wants is the one it’s not allowed to use.

Ava: From the checkout to the data center. Oracle is building the AI cloud with borrowed money and a shrinking payroll. The company cut 21,000 jobs over the past year, about 13% of the workforce, while it pours money into infrastructure.[^orcl-layoffs-20260627] Free cash flow for fiscal 2026 swung to a deficit of nearly $24 billion, driven by $55.7 billion in capital spending.[^orcl-fcf-20260627] And it’s guiding next year to $90 billion in revenue while planning to raise another $40 billion in debt.[^orcl-guidance-20260627][^orcl-financing-20260627] Marcus, what does that infrastructure actually cost?

Marcus: It costs the balance sheet, and Oracle’s making that bet out loud. There’s no multiple to anchor here — when you spend $55.7 billion on capex and free cash flow runs a $24 billion deficit, the price-to-cash-flow frame just doesn’t apply.[^memo-orcl-fcf-20260627] So don’t pretend it does. What you’re actually underwriting is whether $40 billion in fresh debt turns into $90 billion of durable cloud revenue, or into stranded capacity.

Ava: A bet, not a business yet.

Marcus: Not yet. And the tell will be the financing. Oracle already raised $43 billion in debt this past year, and it’s planning $40 billion more.[^orcl-financing-20260627] When a company funds the build with the bond market instead of its own cash flow, the bond market gets a vote on the strategy. On page 2 of the memo, Oracle sits right next to Broadcom — the two sides of the same AI infrastructure trade. One is borrowing to build it. The other is selling the shovels at a profit. Hold that thought.

Deep dive — Micron and Broadcom

Ava: Here’s the deep dive, and it’s really one argument. Same week, same end-market, two completely different stories. Micron printed the memory supercycle in raw numbers. Broadcom showed you exactly what the hyperscalers will pay to escape its downstream cost. Two sides of one trade.

Ava: The headlines, side by side. Micron reported fiscal Q3 revenue of $41.5 billion — against prior guidance of around $24 billion — and then guided next quarter to $50 billion, when Wall Street was modeling $43 billion.[^mu-q3-revenue-20260627][^mu-q4-guidance-20260627] The stock jumped 16% and the market cap crossed $1 trillion.[^mu-stock-surge-20260627][^mu-market-cap-20260627] Meanwhile Broadcom and OpenAI unveiled a custom inference chip called Jalapeño, built to cut AI inference cost by about half versus a standard GPU.[^avgo-jalapeno-chip-20260627][^avgo-jalapeno-cost-20260627] Marcus — which one is the bigger surprise?

Marcus: Micron, and it’s not close. Going into this print the memo had Micron at 102 times trailing free cash flow — and I want to be clear, those numbers are now ancient history; we re-anchor when the fiscal-year filing lands.[^memo-mu-evfcf-20260627] Forget the multiple. The thing that matters is buried in the release: 16 legally binding take-or-pay contracts that lock in roughly 20% of Micron’s DRAM capacity through the end of 2030.[^mu-customer-agreements-20260627] That’s not a cycle. A cycle is when prices spike and supply floods in to kill them. This is customers signing five-year contracts to guarantee they get product at all. The cycle didn’t turn. The structure changed.

Ava: But every memory bull has been burned by the next air pocket. What stops this from rolling over the way it always has?

Marcus: The mix. Micron’s data center revenue went up more than sevenfold year over year, to about $11.5 billion in the quarter.[^mu-datacenter-20260627] The old memory cycle ran on phones and PCs — discretionary demand that turns on a dime. This run is driven by AI training and inference clusters, where the buyer is a hyperscaler signing multi-year capacity. Contracted demand doesn’t air-pocket the way discretionary demand does. The real risk isn’t a sudden glut — it’s that the build pauses. And the take-or-pay contracts are written so that even if a customer pauses, Micron still gets paid. That’s the difference between this and 2018.

Ava: So why is Broadcom the other half of this?

Marcus: Because Jalapeño is what you do when the input you depend on just got that expensive. Broadcom’s memo profile is the mirror image of Micron’s — about 68 times trailing free cash flow at a 1.5% yield, a real cash generator priced like one.[^memo-avgo-evfcf-20260627][^memo-avgo-fcfyield-20260627] And its AI semiconductor revenue is already running over $10 billion a quarter, guided toward more than $100 billion in fiscal 2027.[^avgo-fy2027-guidance-20260627] The Jalapeño chip — 50% cheaper inference, co-designed with OpenAI — is the hyperscalers saying out loud that GPU economics hurt enough to design around. Nvidia is the chip everyone’s now trying to engineer their way past. That’s not a knock on Nvidia. That’s a tell on how expensive the whole stack got.

Ava: And does Jalapeño actually dent Nvidia, or is it a negotiating chip?

Marcus: Both, and that’s the point. One custom processor doesn’t break a software moat that took 15 years to build. But it changes every procurement meeting — now the hyperscaler has a credible second source to wave around. The forward test for Broadcom is just as simple: does that $100 billion fiscal-2027 AI number actually show up, or does it stay a slide in a deck? If it shows up, 68 times trailing was cheap. If it slips, it was the top. Either way, Broadcom gets paid to build the escape hatch.

Marcus: Here’s the line that ties it together. Memory is the new crude oil. And like crude, the people who locked in supply before the price doubled look smarter every single quarter. Micron just signed the people who locked in.

Ava: Memory is the new crude oil. Sit with that one.

Rapid-fire

Ava: Rapid fire. Step away from memory for a minute.

Ava: Nike is the turnaround that keeps not arriving, and Tuesday it gets graded. The company reports Q4 results Tuesday afternoon, with the stock sitting at a 52-week low of $40, down about 35% on the year.[^nke-q4-earnings-20260627][^nke-52wk-low-20260627] KeyBanc downgraded it this week on slow turnaround progress and headwinds in China and Europe.[^nke-keybanc-downgrade-20260627] And here’s the crossover detail — Nike’s new finance chief is David Denton, hired straight out of the Pfizer CFO seat.[^nke-denton-cfo-20260627]

Ava: Which brings us to pharma, where the week was busy. On page 15 of the memo — Pfizer and Moderna. Pfizer got an FDA approval expanding its IBRANCE breast-cancer regimen, and it’s pushing 10 Phase 3 studies this year on its monthly GLP-1, berobenatide — the obesity option the market isn’t really pricing.[^pfe-ibrance-approval-20260627][^pfe-berobenatide-phase3-20260627] Pfizer trades around 16 times free cash flow at a 6% yield, so you’re paid to wait.[^memo-pfe-evfcf-20260627] And Moderna got a unanimous, 9-0 FDA advisory vote backing its mRNA flu vaccine, with a decision due August 5 — which would be the first mRNA flu shot licensed in the US.[^mrna-flu-vac-20260627] The stock jumped about 12% on the news.[^mrna-stock-jump-20260627] Two names, one page, two very different clocks — Pfizer’s a yield-and-optionality story you can hold, Moderna’s a binary that resolves August 5.

Ava: Meta showed you the memory supercycle hitting the biggest ad budget in tech. It raised its 2026 capital spending guide to between $125 and $145 billion, blaming higher component pricing and data-center costs.[^meta-capex-20260627] Same flood, different shore. It also unveiled in-house AI smart glasses at $299 and a prediction-market app called Arena.[^meta-glasses-20260627][^meta-prediction-market-20260627]

Ava: And Tesla — the number to watch lands Thursday. Tesla reports Q2 deliveries July 2, with consensus around 406,000 vehicles and Goldman up at 420,000 on a European recovery.[^tsla-q2-schedule-20260627][^tsla-gs-forecast-20260627] One analyst cut the stock to Sell this week, citing energy storage revenue down 12% and robotaxi delays.[^tsla-downgrade-20260627] The delivery print is the first real read on whether Europe offsets China.

Close

Ava: That’s the show. Wall Street’s consensus on Micron: the memory cycle always rolls over, it always has. 16 take-or-pay contracts running through 2030 say maybe not this time. Keep score with me on that one.

Ava: Forward week: Nike reports Tuesday, Tesla deliveries Thursday, and Moderna’s FDA clock runs toward August 5. Everything you heard today traces back to one chart — the price of memory — and the Cash Flow Memo is where we watch it propagate through all 90-plus names. Download it at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2627.

Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* Apple posts worst day in over a year after MacBook and iPad price hikes. (2026, June 25). CNBC. https://www.cnbc.com/2026/06/25/apple-macbook-ipad-price-hike-memory.html

* Apple seeks US approval to buy chips from blacklisted CXMT: FT. (2026, June 27). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-27/apple-seeks-us-approval-to-buy-chips-from-blacklisted-cxmt-ft

* Apple shares sink after price hikes hit iPads and Macs. (2026, June 25). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-25/apple-raises-mac-and-ipad-prices-to-counter-memory-shortages

* Apple’s Vision Pro and smart glasses chief Paul Meade is leaving for OpenAI. (2026, June 26). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-26/apple-s-vision-pro-and-smart-glasses-chief-paul-meade-is-leaving-for-openai

* Broadcom (AVGO) earnings report Q2 2026. (2026, June 3). CNBC. https://www.cnbc.com/2026/06/03/broadcom-avgo-earnings-report-q2-2026.html

* FDA advisory panel votes 9-0 in favor of Moderna’s mRNA flu vaccine, setting stage for August decision. (2026, June 18). BioPharm International. https://www.biopharminternational.com/view/fda-advisory-panel-votes-9-0-in-favor-of-moderna-s-mrna-flu-vaccine-setting-stage-for-august-decision

* FDA approves Pfizer’s IBRANCE regimen for HR+, HER2+ metastatic breast cancer frontline maintenance. (2026, June 24). BusinessWire. https://www.businesswire.com/news/home/20260617408304/en/FDA-Approves-Pfizers-IBRANCE-Regimen-for-HR-HER2-Metastatic-Breast-Cancer-Frontline-Maintenance

* Goldman Sachs raises Tesla Q2 2026 delivery forecast to 420K. (2026, June 26). Basenor. https://www.basenor.com/blogs/news/goldman-sachs-raises-tesla-q2-2026-delivery-forecast-to-420k

* KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty. (2026, June 26). Investing.com. https://www.investing.com/news/stock-market-news/keybanc-lowers-nike-rating-to-sector-weight-on-nearterm-uncertainty-4762387

* Meta plans to release AI-powered prediction market app, documents show. (2026, June 24). NPR. https://www.npr.org/2026/06/24/nx-s1-5869486/meta-prediction-market-app-ai

* Meta Platforms, Inc. (2026). Form 8-K, FY2026 [Q1 results / 2026 capex guidance]. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/0001326801/000162828026003832/meta-12312025xexhibit991.htm

* Micron posts $41.5B Q3 revenue, guides Q4 to $50B. (2026, June 24). StockTitan. https://www.stocktitan.net/news/MU/micron-technology-inc-reports-record-results-for-the-third-quarter-6f50161e5zxh.html

* Micron sales forecast tops estimates on memory-chip demand. (2026, June 24). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-24/micron-sales-forecast-tops-estimates-on-insatiable-memory-demand

* Micron stock hits record high after Q3 earnings. (2026, June 24). TradingKey. https://www.tradingkey.com/analysis/stocks/us-stocks/261995206-micron-mu-q3-memory-shortage-cycle-ai-2027-samsung-skhynix-capex-tradingkey

* Micron Technology stock could go parabolic after June 24. Here’s why. (2026, June 24). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/prediction-micron-technology-stock-could-110200571.html

* MRNA stock surges as flu win and pipeline shift grab attention. (2026, June 26). Timothy Sykes News. https://www.timothysykes.com/news/moderna-inc-mrna-news-2026_06_26-2/

* Nike names Pfizer CFO David Denton as next finance chief. (2026, June 23). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-23/nike-hires-pfizer-cfo-denton-to-take-over-for-departing-friend

* NIKE, Inc. (2026, June). NIKE, Inc. announces fourth quarter fiscal 2026 earnings and conference call [Press release]. Nike Investor Relations. https://investors.nike.com/investors/news-events-and-reports/investor-news/investor-news-details/2026/NIKE-Inc–Announces-Fourth-Quarter-Fiscal-2026-Earnings-and-Conference-Call/default.aspx

* Nike stock hits 52-week low. (2026, June 26). Investing.com. https://www.investing.com/news/company-news/nike-stock-hits-52week-low-at-4132-usd-93CH-4758516

* Broadcom Inc. (2026, June 24). OpenAI and Broadcom unveil LLM-optimized intelligence processor [Press release]. Broadcom Investor Relations. https://investors.broadcom.com/news-releases/news-release-details/openai-and-broadcom-unveil-llm-optimized-intelligence-processor

* OpenAI launches custom AI chip Jalapeño with Broadcom (AVGO). (2026, June 24). GuruFocus. https://www.gurufocus.com/news/8930240/openai-launches-custom-ai-chip-jalapeno-with-broadcom-avgo

* Oracle Corporation. (2026, June 10). Oracle announces record Q4 and FY 2026 results driven by Cloud Infrastructure & Cloud Applications [Press release]. Oracle Investor Relations. https://investor.oracle.com/investor-news/news-details/2026/Oracle-Announces-Record-Q4-and-FY-2026-Results-Driven-by-Cloud-Infrastructure–Cloud-Applications/default.aspx

* Oracle lays off 21,000 employees in just 12 months due to AI adoption and costly AI infrastructure ambitions. (2026, June 23). Tom’s Hardware. https://www.tomshardware.com/tech-industry/artificial-intelligence/oracle-lays-off-21-000-employees-in-just-12-months-due-to-ai-adoption-and-costly-ai-infrastructure-ambitions-says-layoffs-will-continue-as-internal-ai-deployment-grows

* Oracle Q4 earnings and revenue top estimates; hyperscaler plans more debt issuance to support massive capex push. (2026, June 11). Sherwood News. https://sherwood.news/tech/oracle-q4-earnings-and-revenue-top-estimates/

* Oracle shares slide as hefty AI spending, debt plans spook investors. (2026, June 11). The Spokesman-Review. https://www.spokesman.com/stories/2026/jun/11/oracle-shares-slide-as-hefty-ai-spending-debt-plan/

* Robust Phase 2b efficacy and favorable tolerability support monthly dosing for Pfizer’s GLP-1 RA berobenatide. (2026, June 5). BioSpace. https://www.biospace.com/press-releases/robust-phase-2b-efficacy-and-favorable-tolerability-support-monthly-dosing-for-pfizers-glp-1-ra-berobenatide

* Tesla downgraded to Sell, citing energy storage and robotaxi delays. (2026). Yahoo Finance. https://finance.yahoo.com/news/tesla-stock-drops-as-new-morgan-stanley-analyst-downgrades-shares-citing-valuation-164741776.html

* Tesla Q2 2026 analyst delivery consensus. (2026, June 26). Electrek. https://electrek.co/2026/06/26/tesla-q2-2026-delivery-consensus-406000/

Internal data

Internal data is provided on a best efforts basis.